IE
ORIC icon

Israel Englander’s Oric Pharmaceuticals ORIC Stock Holding History

Israel Englander’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.56M Buy
697,694
+663,682
+1,951% +$6.02M ﹤0.01% 2590
2026
Q1 		$431K Sell
34,012
-63,420
-65% -$720K ﹤0.01% 4842
2025
Q4 		$797K Sell
97,432
-43,001
-31% -$495K ﹤0.01% 4644
2025
Q3 		$1.69M Sell
140,433
-210,102
-60% -$2.21M ﹤0.01% 4207
2025
Q2 		$3.56M Buy
350,535
+296,552
+549% +$1.99M ﹤0.01% 3331
2025
Q1 		$301K Buy
53,983
+26,349
+95% +$230K ﹤0.01% 5101
2024
Q4 		$223K Sell
27,634
-265,889
-91% -$2.44M ﹤0.01% 5245
2024
Q3 		$3.01M Sell
293,523
-488,776
-62% -$4.83M ﹤0.01% 3313
2024
Q2 		$5.53M Buy
782,299
+585,447
+297% +$5.24M ﹤0.01% 2639
2024
Q1 		$2.71M Buy
+196,852
New +$2.34M ﹤0.01% 3468
2023
Q4 		– Sell
-1,163,760
Closed -$7.04M – 6404
2023
Q3 		$7.04M Buy
1,163,760
+7,650
+0.7% +$62.7K ﹤0.01% 2387
2023
Q2 		$8.97M Sell
1,156,110
-1,111,532
-49% -$6.31M ﹤0.01% 2128
2023
Q1 		$12.9M Buy
2,267,642
+383,664
+20% +$2M 0.01% 1714
2022
Q4 		$11.1M Buy
1,883,978
+355,370
+23% +$1.2M 0.01% 2024
2022
Q3 		$4.89M Buy
1,528,608
+86,631
+6% +$347K ﹤0.01% 2905
2022
Q2 		$6.46M Buy
1,441,977
+1,064,486
+282% +$4.25M ﹤0.01% 2530
2022
Q1 		$2.02M Buy
+377,491
New +$3.4M ﹤0.01% 3874
2021
Q3 		– Sell
-231,853
Closed -$4.1M – 7112
2021
Q2 		$4.1M Buy
231,853
+108,396
+88% +$2.38M ﹤0.01% 3026
2021
Q1 		$3.02M Buy
123,457
+21,595
+21% +$682K ﹤0.01% 3127
2020
Q4 		$3.45M Buy
101,862
+77,372
+316% +$2.22M ﹤0.01% 2795
2020
Q3 		$612 Buy
+24,490
New +$583K ﹤0.01% 3467

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Israel Englander's ORIC Position: Q2 2026 in Review

Israel Englander increased its Oric Pharmaceuticals (ORIC) stake by 1,951% in Q2 2026, buying an estimated $6.02M and bringing the position to 697,694 shares worth $7.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

Israel Englander first reported a position in ORIC in Q3 2020 and has held it in 21 quarters since. The position peaked at $12.9M in Q1 2023. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Israel Englander held 697,694 shares of Oric Pharmaceuticals worth $7.56M as of Q2 2026.
  • Israel Englander bought 663,682 Oric Pharmaceuticals shares in Q2 2026, an estimated $6.02M.
  • Oric Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2590 holding.
  • Israel Englander first reported a position in Oric Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • Israel Englander's Oric Pharmaceuticals position peaked at $12.9M in Q1 2023.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.